News

Neuromod raises €5.5m to fund clinical trials for a device that targets Tinnitus

Manus Rogan, managing partner of Fountian Healthcare Partners and Ross O’Neill, founder and chief executive of Neuromod.

Tuesday, 29 September 2015

Commercialisation Newsletter Q3 2015

Welcome to our quarterly Commercialisation newsletter

Friday, 25 September 2015

Maynooth University and Aquamarine Power collaborate to accelerate development of commercial wave energy

Professor John Ringwood from the Centre for Ocean Energy Research at Maynooth University has been awarded EU Horizon 2020 funding to collaborate with Scottish company, Aquamarine Power, in the development of commercial wave energy technology.

Wednesday, 16 September 2015

Commercialisation Newsletter Q2 2015

Our latest edition of the Commercialisation Newsletter

Tuesday, 30 June 2015

Annual Commercialisation Award

Dr Shirley O'Dea, Maynooth University Biology Department and Avectas Limited, receiving the Annual Commercialisation Award from Professor Bernard Mahon, VP for Research

Tuesday, 21 April 2015

Commercialisation Newsletter Q1 2015

Commercialisation Newsletter Q1 2015

Thursday, 26 February 2015

Adapt Pharma invests in Maynooth University tech spin-off

Profector Life Sciences has scientific instruments business selling devices that allow researchers to deliver molecules to cultured cells

Monday, 05 January 2015

Communications - Intunative - Maynooth University

Maynooth University spinout launches new music creation app

Maynooth University spinout, 'Surface Tension,' launches a unique musical instrument for tablets.

Tuesday, 23 December 2014

Commercialisation Newsletter Q4 2014

Wishing all our readers a Happy and Healthy Christmas.

Thursday, 18 December 2014

Communications - Maynooth researcher awarded SFI and Pfizer Inc funding - Maynooth University

Maynooth researcher awarded SFI and Pfizer Inc funding

Professor Paul Moynagh, Maynooth University awarded funding to research uncontrolled inflammation causes diseases like Crohn’s disease, psoriasis, and rheumatoid arthritis.

Thursday, 18 December 2014

Pages